JANET PETERS: Open Payments
NPI 1396448726 · SAINT JOSEPH, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$450 in 18 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $1,045 · 2025 $450
Food & beverage: $450
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $169 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $86 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
| Novo Nordisk Inc | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
| Gilead Sciences, Inc. | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $17 |
Products named: RINVOQ, ENTYVIO, XIFAXAN, SKYRIZI, Wegovy, MAVYRET, DUPIXENT, IQIRVO.
Industry payments across MI — which companies pay providers there.
